Chemokine (C-C) motif ligand 20 is regulated by PGF2α-F-prostanoid receptor signalling in endometrial adenocarcinoma and promotes cell proliferation

Molecular and Cellular Endocrinology

Volumn 331, Issue 1, 2011, Pages 129-135

  Wallace, Alison E ^a   Catalano, Rob D ^a   Anderson, Richard A ^a   Jabbour, Henry N ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

CCL20; CCR6; Chemokine; Endometrial cancer; F prostanoid receptor; PGF2

Indexed keywords

CALCINEURIN; CHEMOKINE RECEPTOR CCR6; EPIDERMAL GROWTH FACTOR RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN F2 ALPHA; TRANSCRIPTION FACTOR NFAT;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINE CCL20; DINOPROST; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SPACE; MODELS, BIOLOGICAL; PROTEIN TRANSPORT; RECEPTORS, CCR6; RECEPTORS, PROSTAGLANDIN; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 78149408573     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.08.018     Document Type: Article

References (32)

1. Baumforth K.R., et al. Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells. Am. J. Pathol. 2008, 173:195-204.
2. Beider K., et al. Interaction between CXCR4 and CCL20 pathways regulates tumor growth. PLoS One 2009, 4:e5125.
3. Bonnotte B., et al. MIP-3alpha transfection into a rodent tumor cell line increases intratumoral dendritic cell infiltration but enhances (facilitates) tumor growth and decreases immunogenicity. J. Immunol. 2004, 173:4929-4935.
4. Brand S., et al. Cell differentiation dependent expressed CCR6 mediates ERK-1/2. SAPK/JNK, and Akt signalling resulting in proliferation and migration of colorectal cancer cells. J. Cell. Biochem. 2006, 97:709-723.
5. Bush C.R., et al. Functional genomic analysis reveals cross-talk between peroxisome proliferator-activated receptor gamma and calcium signalling in human colorectal cancer cells. J. Biol. Chem. 2007, 282:23387-23401.
6. Campbell A.S., et al. Macrophage inflammatory protein-3alpha promotes pancreatic cancer cell invasion. J. Surg. Res. 2005, 123:96-101.
7. Clipstone N.A., et al. Molecular analysis of the interaction of calcineurin with drug-immunophilin complexes. J. Biol. Chem. 1994, 269:26431-26437.
8. Dellacasagrande J., et al. Liver metastasis of cancer facilitated by chemokine receptor CCR6. Scand J. Immunol. 2003, 57:534-544.
9. Doll A., et al. Novel molecular profiles of endometrial cancer-new light through old windows. J. Steroid Biochem. Mol. Biol. 2008, 108:221-229.
10. Ghadjar P., et al. Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer. J. Cancer Res. Clin. Oncol. 2008, 134:1181-1189.
11. Ghosh M., et al. CCL20/MIP3alpha is a novel anti-HIV-1 molecule of the human female reproductive tract. Am. J. Reprod. Immunol. 2009, 62:60-71.
12. Harris C.D., et al. Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin 1 (or RCAN1) in disease. Cell Mol. Life Sci. 2005, 62:2477-2486.
13. Jabbour H.N., Boddy S.C. Prostaglandin E2 induces proliferation of glandular epithelial cells of the human endometrium via extracellular regulated kinase 1/2-mediated pathway. J. Clin. Endocrinol. Metab. 2003, 88:4481-4487.
14. Kanda N., et al. Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur. J. Immunol. 2009, 39:996-1006.
15. Macian F., et al. Partners in transcription: NFAT and AP-1. Oncogene 2001, 20:2476-2489.
16. Maldonado-Perez D. Prokineticin 1 modulates IL-8 expression via the calcineurin/NFAT signalling pathway. Biochim Biophys Acta 2009, 1793:1315-1324.
17. Pietila T.E., et al. Multiple NF-kappaB and IFN regulatory factor family transcription factors regulate CCL19 gene expression in human monocyte-derived dendritic cells. J. Immunol. 2007, 178:253-261.
18. Rubie C., et al. Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma. Scand J. Immunol. 2006, 63:468-477.
19. Sales K.J., et al. Prostaglandin E2 mediates phosphorylation and down-regulation of the tuberous sclerosis-2 tumor suppressor (tuberin) in human endometrial adenocarcinoma cells via the Akt signalling pathway. J. Clin. Endocrinol. Metab. 2004, 89:6112-6118.
20. Sales K.J., et al. Expression, localization, and signalling of prostaglandin F2 alpha receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signalling pathways. J. Clin. Endocrinol. Metab. 2004, 89:986-993.
21. Sales K.J., et al. A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas. Cancer Res. 2005, 65:7707-7716.
22. Sales K.J., et al. Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element. Mol. Cell Endocrinol. 2008, 285:51-61.
23. Sales K.J., et al. Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway. Biochim. Biophys. Acta 2009, 1793:1917-1928.
24. Sandri S., et al. Serum amyloid A induces CCL20 secretion in mononuclear cells through MAPK (p38 and ERK1/2) signalling pathways. Immunol. Lett. 2008, 121:22-26.
25. Schutyser E., et al. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 2003, 14:409-426.
26. Slettenaar V.I., Wilson J.L. The chemokine network: a target in cancer biology?. Adv. Drug Deliv. Rev. 2006, 58:962-974.
27. Sun B., et al. Expression of macrophage inflammatory protein-3alpha in an endometrial epithelial cell line, HHUA, and cultured human endometrial stromal cells. Mol. Hum. Reprod. 2002, 8:930-933.
28. Takasaki J., et al. A novel Galphaq/11-selective inhibitor. J. Biol. Chem. 2004, 279:47438-47445.
29. Wallace A.E., et al. Prostaglandin F2alpha-F-prostanoid receptor signalling promotes neutrophil chemotaxis via chemokine (C×C motif) ligand 1 in endometrial adenocarcinoma. Cancer Res. 2009, 69:5726-5733.
30. Wang L., et al. TLR4 signalling in cancer cells promotes chemoattraction of immature dendritic cells via autocrine CCL20. Biochem. Biophys. Res. Commun 2008, 366:852-856.
31. Wong Y.F., et al. Identification of molecular markers and signalling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. Oncogene 2007, 26:1971-1982.
32. Zhu B., et al. Administration of MIP-3alpha gene to the tumor following radiation therapy boosts anti-tumor immunity in a murine model of lung carcinoma. Immunol. Lett. 2006, 103:101-107.